Sol-Gel Technologies Ltd. Ordinary Shares
Symbol: SLGL (NASDAQ)
37.52
▲ (27.17%) 8.015
Company Description:
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Key Stats
- Today's Open: $30.79
- Today's High: $37.515
- Today's Low: $29.8
- Today's Volume: 22.80K
- Yesterday Close: $29.5
- Yesterday High: $29.86
- Yesterday Low: $27
- Yesterday Volume: 4.33K
- Last Min Volume: 1
- Last Min High: $37.515
- Last Min Low: $37.515
- Last Min VWAP: $37.515
Company Profile
- Name: Sol-Gel Technologies Ltd. Ordinary Shares
- Website: https://www.sol-gel.com
- Listed Date: 2018-02-01
- Location: ,
- Market Status: Active
- CIK Number: 0001684693
- SIC Code:
- SIC description:
- Market Cap: $96.95M
- Round Lot: 100
- Outstanding Shares: 2.79M
- Asset Type: CS
RECENT FILINGS FOR SLGL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-25 | 6-K | View |
| 2025-09-04 | 6-K | View |
| 2025-08-29 | SCHEDULE 13G | View |
| 2025-08-18 | EFFECT | View |
| 2025-08-15 | POS AM | View |
| 2025-08-15 | 6-K | View |
| 2025-06-12 | SCHEDULE 13D/A | View |
| 2025-05-23 | 424B3 | View |
| 2025-05-23 | 6-K | View |
| 2025-05-22 | 6-K | View |
| 2025-05-08 | EFFECT | View |
| 2025-05-08 | 424B3 | View |
| 2025-05-08 | 6-K/A | View |
| 2025-05-06 | CORRESP | View |
| 2025-05-05 | 6-K | View |
| 2025-05-02 | UPLOAD | View |
| 2025-04-30 | EFFECT | View |
| 2025-04-30 | SCHEDULE 13D/A | View |
| 2025-04-29 | F-3 | View |
| 2025-04-29 | S-8 | View |
Latest News on SLGL